Skip to content

Lisbon conference news: Nevirapine performs strongly in high viral load patients

Thailand to start producing own version of d4T

Hydroxyurea - when is the best time to use it?

Risk of interactions between Zyban & HAART

Taking Heart: biggest ever survey of UK HIV+ makes fascinating reading

Twice daily nelfinavir approved in US

Delavirdine not associated with lipid increases in newly treated

Ritonavir mini-dose improves efavirenz/amprenavir salvage prospects

Tenofovir: low resistance risk for new drug after six months therapy